A severe heat wave is causing an uptick in heat-related emergency visits; Leqembi set to be rolled out in the coming months; declining childhood vaccination rate raises concerns over winter surge.
Heat Wave Strains EMS as Heat-Related Calls Surge
The ongoing heat wave in many cities across the United States, New Orleans among them, has put a significant strain on emergency medical services (EMS), leading to a surge in heat-related emergency calls, according to Kaiser Health News. With temperatures in New Orleans exceeding 105ºF and dangerous heat levels becoming more common, the city’s EMS has been working tirelessly to respond to the escalating health crises. However, the department is facing challenges such as limited staffing and funding, making it more difficult to keep up with the growing demands for medical assistance during extreme heat conditions. According to scientists, these heat levels will continue to go up, leading to an ever-increasing strain on funding and staffing challenges from having to deal with the aftermath.
Alzheimer Drug Leqembi Expected to Be Available Soon
Five major US health systems are gearing up to offer lacenemab (Leqembi), the first Alzheimer disease drug proven to slow disease progression in the earliest stages, according to Reuters. The drug received full FDA regulatory approval last month, leading to an increased demand for treatment from patients. However, health systems are carefully working through issues related to payment, diagnostic testing, and patient evaluation, which may slow down the initial rollout. Nonetheless, the approval and anticipated loosening of Medicare imaging policies are expected to accelerate access to the treatment, benefitting an estimated 6.5 million Americans affected by Alzheimer disease.
Childhood Vaccine Coverage Declined
Childhood vaccine coverage in the United States has seen a slight decline, with the rate of vaccinations against measles, mumps, and rubella for kindergarteners dropping to 93%, below the recommended 95% target for herd immunity, according to The Hill. Experts are concerned about potential disease surges, particularly amid preparations for a fall COVID-19 vaccine campaign. Furthermore, vaccine hesitancy, financial constraints, and vaccine fatigue pose challenges to increasing vaccination rates, with parents encouraged to engage in discussions with health care providers to protect their children as they head into the new school year and the upcoming winter season.
Contributor: For Complex Cases, Continuity in Acute Care Is Necessary
April 23rd 2025For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical home—yet each visit is a fragmented restart, without continuity, context, or a clear path forward.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More